SANOFI

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
>
Registration as it was on 30 Sep 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,250,000€ - 1,499,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

3.15 Fte (11)

Lobbyists with EP accreditation

0

High-level Commission meetings

26

Lobbying Costs over the years

  • Info

    SANOFI

    EU Transparency Register

    61291462764-77 First registered on 11 Dec 2009

    Goals / Remit

    Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
    We are driven by a unifying purpose and a common ambition. We believe our cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine, turning the impossible into possible for millions of people around the world. With more than 100,000 people in 100 countries, we chase the miracles of science to improve people’s lives.

    Main EU files targeted

    - Digital in Healthcare
    - European Health Data Space
    - Health Emergency Response Authority
    - pandemic preparedness
    - cross-border health threats
    - shortages of medicines/EU Structured Dialogue
    - manufacturing/value-chain of pharmaceuticals/industrial strategy
    - EU Vaccines policies and vaccine-related activities
    - European green deal agenda
    - EU pharmaceutical strategy
    - EU Competitiveness and Industrial policy
    - EU Research policy / framework program
    - EU options for improving access to medicines
    - Health Technology Assessment Regulation
    - Innovative Medicines Initiative (IMI)
    - Medical Devices Regulation
    - Paediatric Regulation
    - Pharmaceuticals in the environment
    - Protection of animals used for scientific purposes Directive
    - Regulation on Orphan Medicinal Products
    - Reach
    - Trade Agreements
    - Self-care

    Address

    Head Office
    SANOFI GROUPE 54, rue la Boétie
    Paris 75008
    FRANCE
    EU Office
    14 rue de la Science
    Brussels 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    11

    Employment timeLobbyists
    75%1
    50%2
    25%4
    10%4

    Lobbyists (Full time equivalent)

    3.15

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 04 Oct 2022

    Name Start date End Date
    Ms Milena RICHTER 18 Oct 2019 16 Oct 2020
    Ms Clara ZACHMANN 01 Oct 2019 30 Sep 2020
    Mr Jérémy Alain MICHEL 05 Oct 2018 04 Oct 2019
    Ms Milena RICHTER 05 Oct 2018 04 Oct 2019
    Ms Clara ZACHMANN 19 Sep 2018 18 Sep 2019
    Ms Katharina Lotz 17 Apr 2018 16 Apr 2019
    Mr Jérémy Alain MICHEL 30 Oct 2017 26 Oct 2018
    Ms Milena RICHTER 30 Oct 2017 27 Oct 2018
    Ms Clara ZACHMANN 16 Sep 2017 14 Sep 2018
    Mr Darren KINSELLA 24 Mar 2017 22 Mar 2018
    Ms Milena RICHTER 19 Nov 2016 17 Nov 2017
    Mr Jérémy Alain MICHEL 17 Nov 2016 15 Nov 2017
    Mr Darren KINSELLA 23 Mar 2016 21 Mar 2017
    Ms Corinne ASSOULINE-DUGUAY 05 Mar 2016 03 Mar 2017
    Mr Jérémy Alain MICHEL 18 Nov 2015 16 Nov 2016
    Ms Milena RICHTER 18 Nov 2015 16 Nov 2016
    Mr Hannu JOUHKI 10 Mar 2015 06 Mar 2016
    Ms Corinne ASSOULINE-DUGUAY 27 Feb 2015 25 Feb 2016
    Ms Corinne ASSOULINE-DUGUAY 21 Feb 2014 19 Feb 2015
    Ms Milena RICHTER 19 Nov 2014 17 Nov 2015
    Mr Jérémy Alain MICHEL 19 Nov 2014 17 Nov 2015
    Mrs Milena RICHTER 19 Nov 2014 17 Nov 2015
    Mr Hannu JOUHKI 04 Mar 2014 28 Feb 2015
    Mrs Corinne ASSOULINE-DUGUAY 21 Feb 2014 19 Feb 2015
    Mr Jérémy Alain MICHEL 09 Nov 2013 07 Nov 2014
    Mrs Milena RICHTER 18 May 2013 16 May 2014
    Mrs Corinne ASSOULINE épouse DUGUAY 28 Feb 2013 22 Feb 2014
    Mr Erick Denis François Robert TYSSIER 22 Jan 2013 27 Nov 2013
    Mrs Danuta Marianna RYDLEWSKA 23 Jan 2013 27 Nov 2013
    Mr Jérémy Alain MICHEL 22 Jan 2013 27 Nov 2013
    Mr Erick Denis François Robert TYSSIER 22 Feb 2012 31 Dec 2012
    Mrs Danuta Marianna RYDLEWSKA 01 Feb 2012 31 Jan 2013
    Mr Jérémy Alain MICHEL 01 Feb 2012 31 Jan 2013
    Mr Grégory LAMORY 02 Feb 2012 31 Jan 2013

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Professional associations:
    AESGP - Association of the European Self-Medication Industry
    AIM - European Brands Associations
    AFEP (French Association of Private Companies)
    EFPIA - European Federation of Pharmaceutical Industries and Associations)
    Europabio
    FSE (Food Supplements Europe)
    Vaccines Europe
    EUCOPE
    France Industrie

    Think tanks :
    Science Business
    CCE (Conseil de Coopération Economique)
    European Council Studies

    Consulting:
    Acumen
    BCG
    Darwin Associates
    Edelman

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    1,250,000€ - 1,499,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    acumen 10,000€ - 24,999€
    eurosagency 10,000€ - 24,999€
    bcg 25,000€ - 49,999€
    fti 25,000€ - 49,999€
    edelman 50,000€ - 99,999€

    Intermediaries for current year

    Name
    acumen
    darwin associates
    edelman

    Closed year Costs

    1,250,000€ - 1,499,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Other activities

    Sanofi participates in 3 workstreams within the framework of the EU Structured Dialogue on the Security of Medicines Supply

    Sanofi participation in activities linked to COVID-19 vaccines scale-up within the framework of the HERA Incubator

  • Meetings

    Meetings

    26 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

    • Date 08 Jun 2022 Location call
      Subject health industrial ecosystem, HERA and green transition
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Maurits-Jan Prinz (Cabinet member)
    • Date 03 Feb 2022 Location Videoconference
      Subject Initiatives in the health industrial ecosystem
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Maurits-Jan Prinz (Cabinet member)
    • Date 26 Oct 2021 Location Brussels
      Subject Pharmaceutical sector – trade related issues
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Commission
      • Caroline Boeshertz (Cabinet member)
      • Elina Melngaile (Cabinet member)
      • Kevin Keary (Cabinet member)
      Other Lobbyists
    • Date 16 Jun 2021 Location online
      Subject Supply chains for medicines
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Margaritis Schinas (Vice-President)
      Other Lobbyists
    • Date 26 Mar 2021 Location Videoconference
      Subject Health in the industry policy update
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Eszter Batta (Cabinet member)
    • Date 31 Jan 2021 Location Videoconference
      Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Commission
      • Ursula von der Leyen (President)
      Other Lobbyists
    • Date 23 Nov 2020 Location Brussels (WEBEX)
      Subject Alliances
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Commission
      • Kurt Vandenberghe (Cabinet member)
    • Date 16 Nov 2020 Location Videoconference
      Subject Pharmaceutical manufacturing in the EU
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      • Eszter Batta (Cabinet member)
    • Date 13 Oct 2020 Location Videoconference
      Subject Pharmaceutical manufacturing in the EU
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Eszter Batta (Cabinet member)
      • Thierry Breton (Commissioner)
    • Date 25 May 2020 Location Videoconference
      Subject Perspectives on the fight against COVID-19
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
    • Date 06 Apr 2020 Location Videoconference
      Subject Digitisation of healthcare and innovative e-health solutions.
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 21 Feb 2018 Location Brussels
      Subject HTA; Supplementary Protection Certificates (SPC)
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
      Other Lobbyists
    • Date 25 Jan 2018 Location Brussels
      Subject European patent protection
      Cabinet Cabinet of Commissioner Pierre Moscovici
      Portfolio Economic and Financial Affairs, Taxation and Customs
      Commission
      • Lucie Mattera (Cabinet member)
      Other Lobbyists
    • Date 24 Jan 2018 Location Brussels
      Subject Digital Healthcare
      Cabinet Cabinet of Commissioner Mariya Gabriel
      Portfolio Digital Economy and Society
      Commission
      • Manuel Mateo-Goyet (Cabinet member)
    • Date 24 Jan 2018 Location BRUSSELS
      Subject HTA; E-Health
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
    • Date 10 Oct 2017 Location Brussels
      Subject Life Science in the EU
      Cabinet Cabinet of First Vice-President Frans Timmermans
      Portfolio Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights
      Commission
      • Bernardus Smulders (Cabinet member)
    • Date 18 Apr 2016 Location Brussels, Belgium
      Subject Access to health care including pharmaceuticals in developing countries
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Commission
      • Nils Behrndt (Cabinet member)
    • Date 18 Apr 2016 Location Berlaymont
      Subject EPSC, Interinstitutional relations
      Cabinet Cabinet of President Jean-Claude Juncker
      Portfolio President
      Commission
      • Clara Martinez Alberola (Cabinet member)
    • Date 17 Mar 2016 Location Brussels
      Subject AMR, HTA
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
    • Date 02 Jul 2015 Location Brussels
      Subject vaccinations
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Paula Duarte Gaspar (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
    • Date 03 Jun 2015 Location Brussels
      Subject New College and Better Regulation
      Commission
      • Robert Madelin (Director-General)
      Other Lobbyists
    • Date 07 May 2015 Location Brussels
      Subject Implementation Council Conclusions on Vaccination
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Commission
      • Giulia Del Brenna (Cabinet member)
    • Date 27 Mar 2015 Location Berlaymont
      Subject How to strengthen a European coherent approach with focus on ERA development, ways to reduce the fragmented approach in Europe for evaluation the value of new medicines for improved access for the patient, and means of creating a more dynamic environment for medicine development in Europe and driving an ambitious agenda allowing the European life sciences sector to remain competetive on a global scale.
      Cabinet Cabinet of President Jean-Claude Juncker
      Portfolio President
      Commission
      • Clara Martinez Alberola (Cabinet member)
    • Date 19 Mar 2015 Location Brussels
      Subject New Commission, Investment plan, TTIP
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Commission
      • Juho Romakkaniemi (Cabinet member)
    • Date 19 Feb 2015 Location Berlaymont
      Subject Exchange of views in the perspective to present of Health & Growth and to discuss ERA, medicine development and its access for the patient
      Cabinet Cabinet of President Jean-Claude Juncker
      Portfolio President
      Commission
      • Clara Martinez Alberola (Cabinet member)
    • Date 21 Jan 2015 Location Brussels Belgium
      Subject A reflection on how Europe can move towards the development of a genuine European Research Area, benefiting from closer cooperation between the private and the academic and public sectors and better exploit the links between fundamental and translational research.
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Commission
      • Rolf Carsten Bermig (Cabinet member)
Download this datacard